Analgin (Tablets, Capsules, Solution) Instructions for Use
ATC Code
N02BB02 (Metamizole sodium)
Active Substance
Metamizole sodium (Rec.INN registered by WHO)
Clinical-Pharmacological Group
Analgesic-antipyretic
Pharmacotherapeutic Group
Analgesics; other analgesics and antipyretics; pyrazolones
Pharmacological Action
Analgesic-antipyretic, a pyrazolone derivative. It has analgesic, antipyretic, and anti-inflammatory effects, the mechanism of which is associated with the inhibition of prostaglandin synthesis.
Pharmacokinetics
After oral administration, Metamizole sodium is rapidly hydrolyzed in gastric juice to form the active metabolite 4-methyl-amino-antipyrine, which after absorption is metabolized to 4-formyl-amino-antipyrine and other metabolites.
After IV administration, Metamizole sodium rapidly becomes undetectable.
Sodium metamizole metabolites do not bind to plasma proteins. The largest part of the dose is excreted in the urine in the form of metabolites. Metabolites are excreted in breast milk.
Indications
Pain syndrome of various origins (renal and biliary colic, neuralgia, myalgia; in trauma, burns, after surgery; headache, toothache, menstrual pain). Fever in infectious and inflammatory diseases.
ICD codes
| ICD-10 code | Indication |
| K08.8 | Other specified disorders of teeth and supporting structures (including toothache) |
| K80 | Cholelithiasis [cholelithiasis] (including biliary colic) |
| M79.1 | Myalgia |
| M79.2 | Neuralgia and neuritis, unspecified |
| N23 | Unspecified renal colic |
| N94.4 | Primary dysmenorrhea |
| N94.5 | Secondary dysmenorrhea |
| R50 | Fever of unknown origin |
| R51 | Headache |
| R52.0 | Acute pain |
| R52.2 | Other chronic pain |
| T14.3 | Dislocation, sprain and strain of joint and ligament of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 8A8Z | Headache disorders, unspecified |
| 8E4A.1 | Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system |
| DA0A.Z | Diseases of teeth and supporting structures, unspecified |
| DC11.Z | Cholelithiasis, unspecified |
| FB56 | Specified soft tissue diseases, not elsewhere classified |
| FB56.2 | Myalgia |
| GA34.3 | Dysmenorrhea |
| LA30.5Z | Anomalies of tooth resorption or loss, unspecified |
| MF56 | Renal colic |
| MG26 | Fever of other or unknown origin |
| MG30.Z | Chronic pain syndrome, unspecified |
| MG31.Z | Acute pain, unspecified |
| ND56.3 | Dislocation, sprain or strain of unspecified body region |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Tablets, Capsules, Solution
Administered orally, IM and IV slowly. The dose, method and scheme of application, duration of application are determined individually, depending on the indications, clinical situation, dosage form and age of the patient.
For oral administration, a single dose for adults and adolescents over 15 years of age is 250-500 mg. The maximum single dose is 1000 mg. Frequency of administration – 2-3 times/day. The maximum daily dose is 2000 mg.
For IM or IV administration, a single dose for adults and adolescents over 15 years of age is 500-1000 mg. The maximum single dose is 1000 mg. The maximum daily dose is 2000 mg, frequency of administration 2-3 times/day.
For children aged 3-12 months (body weight 5-9 kg), Metamizole sodium is administered only IM at a dose of 50-100 mg per 10 kg of body weight; frequency – 2-3 times/day.
The duration of application is 1-5 days when prescribed as an analgesic and 1-3 days as an antipyretic.
Adverse Reactions
From the cardiovascular system infrequently – isolated arterial hypotension. After taking sodium metamizole, an isolated transient decrease in blood pressure is possible (possibly pharmacologically determined and not accompanied by other manifestations of anaphylactic/anaphylactoid reactions); in rare cases, the decrease in blood pressure can be very sharp; in fever, a dose-dependent sharp decrease in blood pressure without other signs of a hypersensitivity reaction is also possible; frequency unknown – Kounis syndrome (allergic coronary syndrome, manifested by clinical and laboratory signs of angina pectoris caused by inflammatory mediators).
From the immune system rarely – anaphylactic/anaphylactoid reactions; very rarely – analgesic bronchial asthma; frequency unknown – anaphylactic shock. Anaphylactic or anaphylactoid reactions in very rare cases can be severe and life-threatening. They can occur even if the patient has taken Metamizole sodium many times before without any complications. Such reactions can develop immediately or several hours after taking sodium metamizole, usually within 1 hour. In milder cases, they manifest as skin and mucosal symptoms (itching, burning, redness, urticaria, swelling) or as shortness of breath or gastrointestinal complaints. In severe cases, these reactions progress to generalized urticaria, severe angioedema (especially involving the larynx), severe bronchospasm, cardiac arrhythmia, sharp decrease in blood pressure (sometimes preceded by an increase in blood pressure) and the development of circulatory shock. In persons with analgesic bronchial asthma syndrome with intolerance to analgesic drugs, these reactions usually manifest as attacks of bronchial asthma.
From the skin and subcutaneous tissues infrequently – fixed drug dermatitis; rarely – skin rash; frequency unknown – Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell’s syndrome).
From the hematopoietic and lymphatic system rarely – leukopenia; very rarely – agranulocytosis, including fatal cases and thrombocytopenia; frequency unknown – aplastic anemia, pancytopenia, including fatal cases. These reactions are immunological in nature. They can occur even if the patient has taken Metamizole sodium many times without any complications. Typical symptoms of agranulocytosis are lesions of the mucous membranes (oral cavity and pharynx, anorectal area and genitals), sore throat, fever. However, with the use of antibiotics, these phenomena may be mild. Sometimes, but not always, there is a slight enlargement of the lymph nodes or spleen. ESR is significantly increased, the granulocyte count is sharply reduced or undetectable. As a rule, hemoglobin, erythrocyte and platelet levels remain normal, but deviations are possible. Typical symptoms of thrombocytopenia are increased bleeding tendency and the appearance of petechiae on the skin and mucous membranes. If there is an unexpected deterioration in general condition, fever does not subside or new or painful ulcerations appear on the mucous membranes, especially in the mouth, nose or throat, the treatment strategy involves immediate discontinuation of sodium metamizole, without waiting for the results of laboratory tests. If pancytopenia develops, Metamizole sodium should be discontinued and a complete blood count should be monitored until its parameters return to normal.
From the urinary system: very rarely – in patients with impaired renal function, acute deterioration of renal function (acute renal failure) is possible, in some cases with oliguria, anuria or proteinuria.
General reactions infrequently – possible red coloration of urine due to the presence of the metabolite – rubazonic acid; very rarely – phlebitis.
Local reactions with IM administration – infiltrates at the injection site.
Contraindications
Hypersensitivity to sodium metamizole and other pyrazolone derivatives, as well as to pyrazolidines, for example, phenylbutazone (including patients who have had agranulocytosis due to the use of these drugs); analgesic bronchial asthma or analgesic intolerance (of the urticaria-angioedema type), i.e. patients with bronchospasm or other forms of anaphylactoid reactions (e.g., urticaria, rhinitis, angioedema) in response to the use of salicylates, paracetamol or NSAIDs such as diclofenac, ibuprofen, indomethacin or naproxen; impaired bone marrow hematopoiesis (e.g., after cytostatic therapy) or diseases of the hematopoietic organs; hereditary deficiency of glucose-6-phosphate dehydrogenase (hemolysis); acute intermittent hepatic porphyria (risk of porphyria attacks); pregnancy (for parenteral administration – I and III trimester), breastfeeding period; childhood – various age categories depending on the dosage form and route of administration; for parenteral administration – acute renal or hepatic failure.
With caution: arterial hypotension (systolic blood pressure below 100 mm Hg), decreased blood volume, hemodynamic instability (myocardial infarction, multiple trauma, incipient shock), incipient heart failure, high fever (increased risk of sharp decrease in blood pressure). Diseases in which a significant decrease in blood pressure may be particularly dangerous (patients with severe coronary artery disease and cerebral artery stenosis). Chronic alcohol abuse. With an increased risk of developing severe anaphylactic/anaphylactoid reactions in patients with bronchial asthma, especially in combination with concomitant polypous rhinosinusitis, chronic urticaria and other types of atopy (allergic diseases, in the development of which a significant role is played by a hereditary predisposition to sensitization: hay fever, allergic rhinitis, etc.), alcohol intolerance (reaction even to small amounts of certain alcoholic beverages with symptoms such as itching, lacrimation and pronounced facial redness). For parenteral administration – II trimester of pregnancy. For oral administration – severe impairment of liver and kidney function (use of low doses is recommended due to the possibility of delayed excretion of sodium metamizole); pain of unclear etiology, especially in the abdominal area (consult a doctor before use).
Use in Pregnancy and Lactation
Contraindicated for oral administration during pregnancy. Contraindicated for parenteral administration in the I and III trimesters of pregnancy. Use with caution parenterally in the II trimester of pregnancy.
Contraindicated for use during lactation (breastfeeding).
Use in Hepatic Impairment
Contraindicated for parenteral administration in acute hepatic failure.
Should be used with caution in severe liver dysfunction (use of low doses is recommended due to the possibility of delayed excretion of sodium metamizole).
Use in Renal Impairment
Contraindicated for parenteral administration in acute renal failure.
Should be used with caution in severe renal dysfunction (use of low doses is recommended due to the possibility of delayed excretion of sodium metamizole).
Pediatric Use
Contraindicated for oral administration in children and adolescents under 15 years of age.
Contraindicated for parenteral administration in children under 3 months of age or weighing less than 5 kg.
Contraindicated for IV administration in children aged 3 to 12 months.
Geriatric Use
Should be used with caution in elderly patients. In this category of patients, the use of high doses should be avoided.
Special Precautions
When treating patients receiving cytotoxic agents, as well as children under 5 years of age, treatment with sodium metamizole should be carried out only under medical supervision.
When choosing the method of administration of sodium metamizole, it should be taken into account that parenteral administration is associated with a higher risk of anaphylactic/anaphylactoid reactions.
An increased risk of developing hypersensitivity reactions to Metamizole sodium may be due to the following conditions: analgesic bronchial asthma, especially with concomitant polypous rhinosinusitis; chronic urticaria; alcohol intolerance (hypersensitivity to alcohol), against which even when taking a small amount of certain alcoholic beverages, patients experience sneezing, lacrimation and pronounced facial redness, alcohol intolerance may indicate a previously undiagnosed aspirin asthma syndrome.
Before using sodium metamizole, a thorough patient interview should be conducted. If a risk of developing anaphylactic reactions is identified, administration is possible only after a careful assessment of the expected benefit to the possible risk of using sodium metamizole. In case of using sodium metamizole in such patients, strict medical monitoring of their condition is necessary, and means for providing emergency care in case of development of anaphylactic/anaphylactoid reactions must be available. In predisposed patients, anaphylactic shock may occur, so patients with asthma or atopy should be prescribed Metamizole sodium with caution. Patients who develop anaphylactoid reactions in response to the use of sodium metamizole are also at risk of developing them in response to the use of other non-narcotic analgesics/NSAIDs. Patients who develop anaphylactic or other immune-mediated reactions (e.g., agranulocytosis) in response to the use of sodium metamizole are also at risk of developing them in response to the use of other pyrazolones and pyrazolidines.
Life-threatening skin reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been described with the use of sodium metamizole. If symptoms of SJS and TEN appear, including progressive skin rash, often with blisters or mucosal involvement, treatment with sodium metamizole should be stopped immediately and should not be subsequently administered in this category of patients. Patients should be informed about the symptoms of these diseases. Skin reactions should be carefully monitored, especially during the first weeks of treatment.
With long-term use (more than 7 days), it is necessary to monitor the peripheral blood picture. Against the background of sodium metamizole intake, agranulocytosis may develop. It occurs very rarely, lasts at least a week, is not dose-dependent, can be severe, life-threatening and, in some cases, fatal. Therefore, if symptoms such as unmotivated fever, chills, sore throat, difficulty swallowing, stomatitis, erosive and ulcerative lesions of the oral cavity, vaginitis or proctitis, a decrease in the number of neutrophils in the peripheral blood below 1500/mm3 are detected, it is necessary to immediately consult a doctor and discontinue Metamizole sodium.
If pancytopenia develops, treatment should be stopped immediately, and complete blood count parameters should be monitored until they normalize.
All patients should be informed that pathological changes in the blood may be accompanied by the appearance of symptoms such as general malaise, infections, persistent fever, bruising, bleeding, pallor while taking sodium metamizole, which requires immediate medical attention.
Metamizole sodium can cause isolated hypotensive reactions. These reactions may be dose-dependent. The risk of such reactions is also increased with pre-existing arterial hypotension, decreased blood volume or dehydration, unstable hemodynamics or acute circulatory disturbance (e.g., in patients with myocardial infarction or trauma), in patients with fever. In this regard, such patients should undergo detailed diagnostics and be carefully monitored. To reduce the risk of hypotensive reactions, preventive measures (hemodynamic stabilization) may be required.
In patients in whom a decrease in blood pressure should be avoided at all costs (e.g., with severe coronary artery disease or significant cerebral artery stenosis), Metamizole sodium is allowed to be used with careful monitoring of hemodynamic parameters.
It is unacceptable to use sodium metamizole to relieve acute abdominal pain until their cause is clarified.
In patients with impaired renal or liver function, it is recommended to avoid taking sodium metamizole in high doses due to a decrease in its excretion rate. The sodium content in the product should be taken into account by persons on a low-sodium diet.
IV administration should be carried out very slowly (no more than 1 ml/min) so that at the first signs of anaphylactic/anaphylactoid reactions the administration can be stopped, as well as to minimize the occurrence of isolated hypotensive reactions.
Influence on the ability to drive vehicles and mechanisms
Given the profile of adverse reactions of sodium metamizole, caution should be exercised when driving vehicles, mechanisms, as well as when performing work that requires increased concentration and speed of psychomotor reactions.
Drug Interactions
Metamizole sodium may cause a decrease in the plasma concentration of cyclosporine, so when used simultaneously, the concentration of cyclosporine should be monitored.
With simultaneous use of sodium metamizole with chlorpromazine, the development of severe hypothermia is possible.
Simultaneous use of sodium metamizole and methotrexate or other myelotoxic agents may enhance the hematotoxicity of the latter, especially in elderly patients.
With simultaneous use, the activity of indirect anticoagulants, oral hypoglycemic drugs, corticosteroids, indomethacin is enhanced due to their displacement from binding to blood proteins under the influence of sodium metamizole.
Tricyclic antidepressants, oral contraceptives, allopurinol disrupt the metabolism of sodium metamizole in the liver and increase its toxicity.
Barbiturates, phenylbutazone and other inducers of liver microsomal enzymes weaken the effect of sodium metamizole.
Sedatives and tranquilizers enhance the analgesic effect of sodium metamizole.
With simultaneous use of sodium metamizole, thiamazole increases the risk of developing leukopenia.
Codeine, H2-histamine receptor blockers and propranolol enhance the effects of sodium metamizole.
When used concomitantly with acetylsalicylic acid, Metamizole sodium may reduce the effect of acetylsalicylic acid on platelet aggregation. Therefore, this combination should be used with caution when treating patients taking acetylsalicylic acid as an antiplatelet agent.
When used concomitantly, Metamizole sodium may reduce the blood concentration of bupropion.
It is known that pyrazolone derivatives can interact with indirect anticoagulants, captopril, lithium, and triamterene, and can also affect the efficacy of antihypertensive agents and diuretics.
Due to the increased risk of developing anaphylactic/anaphylactoid reactions during treatment with sodium metamizole, radiocontrast agents, colloidal blood substitutes, and penicillin should not be used.
Myelotoxic medicinal products enhance the manifestation of the hematotoxicity of sodium metamizole.
Storage Conditions
Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 or 100 pcs.
Marketing Authorization Holder
Alvils, LLC (Russia)
Manufactured By
Wuhan Grand Pharmaceutical Group Co. Ltd. (China)
Dosage Form
 |
Analgin | Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 or 100 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml | 1 amp. |
| Metamizole sodium | 500 mg | 1 g |
2 ml – dark glass ampoules (10) – contour cell packaging (1) – cardboard packs.
2 ml – dark glass ampoules (10) – contour cell packaging (10) – cardboard boxes.
Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 10 pcs.
Marketing Authorization Holder
Armavir Biopharmaceutical Plant, FSE (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml |
| Metamizole sodium | 250 mg |
1 ml – ampoules (10) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/2 ml: amp. 10 pcs.
Marketing Authorization Holder
Armavir Biopharmaceutical Plant, FSE (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/2 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml | 1 amp. |
| Metamizole sodium | 250 mg | 500 mg |
2 ml – ampoules (10) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs.
Marketing Authorization Holder
Armavir Biopharmaceutical Plant, FSE (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml |
| Metamizole sodium | 500 mg |
1 ml – ampoules (10) – cardboard packs.
Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 pcs.
Marketing Authorization Holder
Armavir Biopharmaceutical Plant, FSE (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml | 1 amp. |
| Metamizole sodium | 500 mg | 1 g |
2 ml – ampoules (10) – cardboard packs.
Tablets 500 mg: from 3 to 1000 pcs.
Marketing Authorization Holder
Atoll LLC (Russia)
Manufactured By
Ozon, LLC (Russia)
Dosage Form
 |
Analgin | Tablets 500 mg: from 3 to 1000 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a yellowish tint, round, flat-cylindrical, with a score and a bevel.
| 1 tab. | |
| Metamizole sodium monohydrate | 500 mg |
Excipients: microcrystalline cellulose (MCC-101) – 70 mg, povidone K25 – 24 mg, magnesium stearate – 6 mg.
3 pcs. – contour cell packaging (from 1 to 100 pcs.) – cardboard packs.
4 pcs. – contour cell packaging (from 1 to 100 pcs.) – cardboard packs.
10 pcs. – contour cell packaging (from 1 to 100 pcs.) – cardboard packs.
Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 1 ml or 2 ml 5, 10, or 20 pcs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml or 2 ml 5, 10, or 20 pcs.
Marketing Authorization Holder
Atoll LLC (Russia)
Manufactured By
Ozon, LLC (Russia)
Dosage Forms
|
Analgin | Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 1 ml or 2 ml 5, 10, or 20 pcs. |
| Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml or 2 ml 5, 10, or 20 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration as a clear, colorless or slightly yellowish liquid.
| 1 ml | |
| Metamizole sodium monohydrate | 250 mg |
Excipients: water for injections – up to 1 ml.
1 ml – colorless glass ampoules (5) – contour cell packaging (1) – cardboard packs.
1 ml – colorless glass ampoules (5) – contour cell packaging (2) – cardboard packs.
1 ml – colorless glass ampoules (10) – contour cell packaging (1) – cardboard packs.
1 ml – colorless glass ampoules (10) – contour cell packaging (2) – cardboard packs.
2 ml – colorless glass ampoules (5) – contour cell packaging (1) – cardboard packs.
2 ml – colorless glass ampoules (5) – contour cell packaging (2) – cardboard packs.
2 ml – colorless glass ampoules (10) – contour cell packaging (1) – cardboard packs.
2 ml – colorless glass ampoules (10) – contour cell packaging (2) – cardboard packs.
Solution for intravenous and intramuscular administration as a clear, colorless or slightly yellowish liquid.
| 1 ml | |
| Metamizole sodium monohydrate | 500 mg |
Excipients: water for injections – up to 1 ml.
1 ml – colorless glass ampoules (5) – contour cell packaging (1) – cardboard packs.
1 ml – colorless glass ampoules (5) – contour cell packaging (2) – cardboard packs.
1 ml – colorless glass ampoules (10) – contour cell packaging (1) – cardboard packs.
1 ml – colorless glass ampoules (10) – contour cell packaging (2) – cardboard packs.
2 ml – colorless glass ampoules (5) – contour cell packaging (1) – cardboard packs.
2 ml – colorless glass ampoules (5) – contour cell packaging (2) – cardboard packs.
2 ml – colorless glass ampoules (10) – contour cell packaging (1) – cardboard packs.
2 ml – colorless glass ampoules (10) – contour cell packaging (2) – cardboard packs.
Tablets 500 mg: 10 pcs.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – non-cell contour packaging.
10 pcs. – contour cell packaging (1) – cardboard packs.
Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 10 pcs.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml |
| Metamizole sodium | 250 mg |
1 ml – ampoules (10) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/2 ml: amp. 10 pcs.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/2 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml | 1 amp. |
| Metamizole sodium | 250 mg | 500 mg |
2 ml – ampoules (10) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml |
| Metamizole sodium | 500 mg |
1 ml – ampoules (10) – cardboard packs.
Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 pcs.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml | 1 amp. |
| Metamizole sodium | 500 mg | 1 g |
2 ml – ampoules (10) – cardboard packs.
Tablets 500 mg: 10, 20, 30, 40, 50, 60 or 100 pcs.
Marketing Authorization Holder
Biopharmkombinat, LLC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10, 20, 30, 40, 50, 60 or 100 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a yellowish tint, round, flat-cylindrical, with a score and a bevel.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients: macrogol 4000 – 47 mg, magnesium stearate – 3 mg.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
10 pcs. – contour cell packaging (3) – cardboard packs.
10 pcs. – contour cell packaging (4) – cardboard packs.
10 pcs. – contour cell packaging (5) – cardboard packs.
10 pcs. – contour cell packaging (6) – cardboard packs.
10 pcs. – contour cell packaging (10) – cardboard packs.
50 pcs. – jars (1) – cardboard packs.
100 pcs. – jars (1) – cardboard packs.
10 pcs. – contour cell packaging (500) – cardboard boxes (for hospitals).
10 pcs. – contour cell packaging (700) – cardboard boxes (for hospitals).
Tablets 500 mg: 20 pcs.
Marketing Authorization Holder
Biokhimik, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
20 pcs. – dark glass jars (1) – cardboard packs.
Tablets 500 mg: 10 pcs.
Marketing Authorization Holder
Borisov Plant Of Medical Preparations, PJSC (Republic Of Belarus)
Dosage Form
|
Analgin | Tablets 500 mg: 10 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – contour cell packaging (1) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs.
Marketing Authorization Holder
Borisov Plant Of Medical Preparations, PJSC (Republic Of Belarus)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml |
| Metamizole sodium | 500 mg |
1 ml – ampoules (10) – carton packs.
Tablets 500 mg: 10, 20, or 30 pcs.
Marketing Authorization Holder
Velpharm, LLC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10, 20, or 30 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a slightly yellowish tint, round, flat-cylindrical, with a score and a bevel.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients: potato starch, sucrose (powdered sugar), calcium stearate, talc.
10 pcs. – contour cell packs (1) – carton packs.
10 pcs. – contour cell packs (2) – carton packs.
20 pcs. – jars (1) – carton packs.
30 pcs. – jars (1) – carton packs.
Solution for intravenous and intramuscular administration 500 mg/ml: ampoules 10 pcs.
Marketing Authorization Holder
Grotex, LLC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/ml: ampoules 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration in the form of a transparent, colorless or slightly colored liquid.
| 1 ml | |
| Metamizole sodium | 500 mg |
Excipients: sodium hydroxide solution 0.5M – to pH 6.0 – 7.5, water for injections – up to 1 ml.
2 ml – ampoules (5) – contour cell packs (2) – carton packs.
2 ml – ampoules (10) – contour cell packs (1) – carton packs.
Tablets 500 mg: 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – contour cell packs.
10 pcs. – contour non-cell packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 500 mg |
Excipients: water for injections – up to 1 ml.
1 ml – ampoules (5) – contour cell packs (2) – carton packs.
1 ml – ampoules (10) – carton boxes.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 500 mg |
Excipients: water for injections – up to 1 ml.
2 ml – ampoules (5) – contour cell packs (2) – carton packs.
2 ml – ampoules (10) – carton boxes.
Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 1 ml 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 1 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 250 mg |
Excipients: water for injections – up to 1 ml.
1 ml – ampoules (5) – contour cell packs (2) – carton packs.
1 ml – ampoules (10) – carton boxes.
Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 2 ml 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 2 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 250 mg |
Excipients: water for injections – up to 1 ml.
2 ml – ampoules (5) – contour cell packs (2) – carton packs.
2 ml – ampoules (10) – carton boxes.
Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 10 ml 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 10 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 250 mg |
Excipients: water for injections – up to 1 ml.
10 ml – ampoules (5) – contour cell packs (2) – carton packs.
10 ml – ampoules (10) – carton boxes.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 ml 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 500 mg |
Excipients: water for injections – up to 1 ml.
10 ml – ampoules (5) – contour cell packs (2) – carton packs.
10 ml – ampoules (10) – carton boxes.
Tablets 500 mg: 10, 20, 30, 50, 100, or 200 pcs.
Marketing Authorization Holder
Ivanovo Pharmaceutical Factory PJSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10, 20, 30, 50, 100, or 200 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a yellowish tint, round, flat-cylindrical, with a score and a bevel.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients: sucrose – 10 mg, potato starch – 34 mg, talc – 1 mg, calcium stearate monohydrate (calcium stearate 1-hydrate) – 5 mg.
Weight of one tablet – 550 mg.
10 pcs. – contour cell packs (1) – carton packs.
10 pcs. – contour cell packs (2) – carton packs.
10 pcs. – contour cell packs (5) – carton packs.
10 pcs. – contour cell packs (10) – carton packs.
10 pcs. – contour cell packs (20) – carton packs.
20 pcs. – jars (1) – carton packs.
30 pcs. – jars (1) – carton packs.
10 pcs. – contour cell packs (300) – group packs (for hospitals).
10 pcs. – contour cell packs (500) – group packs (for hospitals).
10 pcs. – contour non-cell packs (300) – group packs (for hospitals).
10 pcs. – contour non-cell packs (500) – group packs (for hospitals).
Tablets 500 mg: 500 or 1000 pcs.
Marketing Authorization Holder
Irbit Chemical Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 500 or 1000 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a slightly yellowish tint, round, flat-cylindrical in shape, with a double-sided bevel and a score on one side.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients: sucrose (sugar), talc, potato starch, calcium stearate.
10 pcs. – contour non-cell packs (500) – carton boxes.
10 pcs. – contour cell packs (1000) – carton boxes.
Tablets 500 mg: 10, 20 and 30 pcs.
Marketing Authorization Holder
Marbiopharm, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10, 20 and 30 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – contour non-cell packs.
10 pcs. – contour cell packs.
10 pcs. – contour cell packs (2) – carton packs.
10 pcs. – contour cell packs (3) – carton packs.
Tablets 500 mg: 3, 4, 6, 8, 9, 10, 12, 15, 16, 18, 20, 21, 24, 27, 28, 30, 32, 36, 40, 50, 60, 70, 80, 90 or 100 pcs.
Marketing Authorization Holder
Mega Pharm, CJS (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 3, 4, 6, 8, 9, 10, 12, 15, 16, 18, 20, 21, 24, 27, 28, 30, 32, 36, 40, 50, 60, 70, 80, 90 or 100 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a slightly yellowish tint, round, flat-cylindrical, with a score on one side and bevels on both sides.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients: potato starch, talc, calcium stearate, sucrose.
3 pcs. – contour cell packs (1) – carton packs.
3 pcs. – contour cell packs (2) – carton packs.
3 pcs. – contour cell packs (3) – carton packs.
3 pcs. – contour cell packs (4) – carton packs.
3 pcs. – contour cell packs (5) – carton packs.
3 pcs. – contour cell packs (6) – carton packs.
3 pcs. – contour cell packs (7) – carton packs.
3 pcs. – contour cell packs (8) – carton packs.
3 pcs. – contour cell packs (9) – carton packs.
3 pcs. – contour cell packs (10) – carton packs.
4 pcs. – contour cell packs (1) – carton packs.
4 pcs. – contour cell packs (2) – carton packs.
4 pcs. – contour cell packs (3) – carton packs.
4 pcs. – contour cell packs (4) – carton packs.
4 pcs. – contour cell packs (5) – carton packs.
4 pcs. – contour cell packs (6) – carton packs.
4 pcs. – contour cell packs (7) – carton packs.
4 pcs. – contour cell packs (8) – carton packs.
4 pcs. – contour cell packs (9) – carton packs.
4 pcs. – contour cell packs (10) – carton packs.
10 pcs. – contour cell packs (1) – carton packs.
10 pcs. – contour cell packs (2) – carton packs.
10 pcs. – contour cell packs (3) – carton packs.
10 pcs. – contour cell packs (4) – carton packs.
10 pcs. – contour cell packs (5) – carton packs.
10 pcs. – contour cell packs (6) – carton packs.
10 pcs. – contour cell packs (7) – carton packs.
10 pcs. – contour cell packs (8) – carton packs.
10 pcs. – contour cell packs (9) – carton packs.
10 pcs. – contour cell packs (10) – carton packs.
10 pcs. – polymer jars (1) – carton packs.
20 pcs. – polymer jars (1) – carton packs.
30 pcs. – polymer jars (1) – carton packs.
40 pcs. – polymer jars (1) – carton packs.
50 pcs. – polymer jars (1) – carton packs.
60 pcs. – polymer jars (1) – carton packs.
70 pcs. – polymer jars (1) – carton packs.
80 pcs. – polymer jars (1) – carton packs.
90 pcs. – polymer jars (1) – carton packs.
100 pcs. – polymer jars (1) – carton packs.
Tablets 500 mg: 10 pcs.
Marketing Authorization Holder
Medisorb, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – contour non-cell packs.
10 pcs. – contour cell packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Moscow Pharmaceutical Factory CJS (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – contour non-cell packs.
10 pcs. – contour non-cell packs (1) – carton packs.
10 pcs. – contour non-cell packs (2) – carton packs.
10 pcs. – contour cell packs (1) – carton packs.
10 pcs. – contour cell packs (2) – carton packs.
Solution for injection 50% (500 mg/1 ml): amp. 5 or 10 pcs.
Marketing Authorization Holder
N.A. Semashko Moscow Chemical Pharmaceutical Preparations, JSC (Russia)
Dosage Form
|
Analgin | Solution for injection 50% (500 mg/1 ml): amp. 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for injection 50% | 1 ml |
| Metamizole sodium | 500 mg |
1 ml – ampoules (10) – carton packs.
1 ml – ampoules (5) – contour cell packs (1) – carton packs.
1 ml – ampoules (10) – carton boxes.
Solution for injection 50% (1 g/2 ml): amp. 5 or 10 pcs.
Marketing Authorization Holder
N.A. Semashko Moscow Chemical Pharmaceutical Preparations, JSC (Russia)
Dosage Form
|
Analgin | Solution for injection 50% (1 g/2 ml): amp. 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for injection 50% | 1 ml | 1 amp. |
| Metamizole sodium | 500 mg | 1 g |
2 ml – ampoules (10) – carton packs.
2 ml – ampoules (5) – contour cell packs (1) – carton packs.
2 ml – ampoules (10) – carton boxes.
Tablets 500 mg: 10, 20 or 3000 pcs.
Marketing Authorization Holder
N.A. Semashko Moscow Chemical Pharmaceutical Preparations, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10, 20 or 3000 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – non-cell contour packs.
10 pcs. – contour cell packs.
10 pcs. – contour cell packs (1) – carton packs.
10 pcs. – contour cell packs (2) – carton packs.
10 pcs. – contour cell packs (300) – group packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: ampoules 5 or 10 pcs.
Marketing Authorization Holder
Novosibkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: ampoules 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml |
| Metamizole sodium | 500 mg |
1 ml – ampoules (10) – carton packs.
1 ml – ampoules (5) – contour plastic packs (1) (trays) – carton packs.
Solution for intravenous and intramuscular administration 1 g/2 ml: ampoules 5 or 10 pcs.
Marketing Authorization Holder
Novosibkhimpharm, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 1 g/2 ml: ampoules 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml | 1 amp. |
| Metamizole sodium | 500 mg | 1 g |
2 ml – ampoules (10) – carton packs.
2 ml – ampoules (5) – contour plastic packs (1) (trays) – carton packs.
Solution for intravenous and intramuscular administration 0.5 g/1 ml: amp. 2 ml 10 pcs.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 0.5 g/1 ml: amp. 2 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, colorless or slightly yellowish.
| 1 ml | |
| Metamizole sodium | 0.5 g |
Excipients: water for injections – up to 1 ml.
2 ml – ampoules (5) – contour cassette packs (2) – carton packs.
2 ml – ampoules (10) – carton packs.
2 ml – ampoules (10) – carton boxes.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Organika, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – non-cell contour packs.
10 pcs. – contour cell packs (1) – carton packs.
10 pcs. – contour cell packs (2) – carton packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 5 or 10 pcs.
Marketing Authorization Holder
Promomed Rus LLC (Russia)
Manufactured By
Biokhimik, JSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, colorless or slightly colored.
| 1 ml | |
| Metamizole sodium | 500 mg |
Excipients: water for injections – up to 1 ml.
2 ml – glass ampoules (5) – contour cell packs (1) – carton packs.
2 ml – glass ampoules (5) – contour cell packs (2) – carton packs.
2 ml – glass ampoules (10) – carton packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 10 pcs.
Marketing Authorization Holder
Samson-Med LLC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration in the form of a transparent, colorless or yellowish liquid.
| 1 ml | |
| Metamizole sodium | 500 mg |
Excipients: water for injections.
2 ml – ampoules (10) – carton packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 10 pcs.
Marketing Authorization Holder
Statusfarm LLC (Russia)
Manufactured By
Yerevan Chemical And Pharmaceutical Firm, OJSC (Armenia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration in the form of a transparent, colorless or yellowish liquid.
| 1 ml | |
| Metamizole sodium | 500 mg |
Excipients: water for injections – up to 1 ml.
2 ml – glass ampoules (10) – carton boxes.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Tatkhimpharmpreparaty, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – carton packs.
10 pcs. – non-cell contour packs.
10 pcs. – contour cell packs.
10 pcs. – contour cell packs (2) – carton packs.
10 pcs. – non-cell contour packs (2) – carton packs.
Tablets 500 mg: 10, 20, 30, 40, or 50 pcs.
Marketing Authorization Holder
Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10, 20, 30, 40, or 50 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a slightly yellowish tint, flat-cylindrical in shape, with a bevel and a score.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients: sucrose – 10 mg, potato starch – 34 mg, talc – 1 mg, calcium stearate – 5 mg.
10 pcs. – contour cell packs (1) – carton packs.
10 pcs. – contour cell packs (2) – carton packs.
10 pcs. – contour cell packs (3) – carton packs.
10 pcs. – contour cell packs (4) – carton packs.
10 pcs. – contour cell packs (5) – carton packs.
10 pcs. – contour cell packs (100) – carton boxes (for hospitals).
10 pcs. – contour cell packs (200) – carton boxes (for hospitals).
10 pcs. – contour cell packs (300) – carton boxes (for hospitals).
10 pcs. – contour cell packs (400) – carton boxes (for hospitals).
10 pcs. – contour cell packs (600) – carton boxes (for hospitals).
10 pcs. – contour cell packs (800) – carton boxes (for hospitals).
Solution for intravenous and intramuscular administration 500 mg/ml: 1 ml, 2 ml, or 5 ml amp. 5, 10, 20, 50, or 100 pcs.
Marketing Authorization Holder
Pharmat, LLC (Russia)
Manufactured By
NPC Eskom, PJSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/ml: 1 ml, 2 ml, or 5 ml amp. 5, 10, 20, 50, or 100 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration in the form of a transparent, colorless or yellowish liquid.
| 1 ml | |
| Metamizole sodium monohydrate | 527 mg |
| Equivalent to metamizole sodium content | 500 mg |
Excipients: sodium disulfite – 2 mg, disodium edetate – 0.1 mg, water for injections – up to 1 ml.
1 ml – neutral glass ampoules (5) – contour cell packs (1) – carton packs.
1 ml – neutral glass ampoules (5) – contour cell packs (2) – carton packs.
1 ml – neutral glass ampoules (5) – contour cell packs (4) – carton packs.
1 ml – neutral glass ampoules (5) – contour cell packs (10) – carton packs.
1 ml – neutral glass ampoules (5) – contour cell packs (20) – carton packs.
1 ml – neutral glass ampoules (10) – contour cell packs (1) – carton packs.
1 ml – neutral glass ampoules (10) – contour cell packs (2) – carton packs.
1 ml – neutral glass ampoules (10) – contour cell packs (5) – carton packs.
1 ml – neutral glass ampoules (10) – contour cell packs (10) – carton packs.
2 ml – neutral glass ampoules (5) – contour cell packs (1) – carton packs.
2 ml – neutral glass ampoules (5) – contour cell packs (2) – carton packs.
2 ml – neutral glass ampoules (5) – contour cell packs (4) – carton packs.
2 ml – neutral glass ampoules (5) – contour cell packs (10) – carton packs.
2 ml – neutral glass ampoules (5) – contour cell packs (20) – carton packs.
2 ml – neutral glass ampoules (10) – contour cell packs (1) – carton packs.
2 ml – neutral glass ampoules (10) – contour cell packs (2) – carton packs.
2 ml – neutral glass ampoules (10) – contour cell packs (5) – carton packs.
2 ml – neutral glass ampoules (10) – contour cell packs (10) – carton packs.
5 ml – neutral glass ampoules (5) – contour cell packs (1) – carton packs.
5 ml – neutral glass ampoules (5) – contour cell packs (2) – carton packs.
5 ml – neutral glass ampoules (5) – contour cell packs (4) – carton packs.
5 ml – neutral glass ampoules (5) – contour cell packs (10) – carton packs.
5 ml – neutral glass ampoules (5) – contour cell packs (20) – carton packs.
5 ml – neutral glass ampoules (10) – contour cell packs (1) – carton packs.
5 ml – neutral glass ampoules (10) – contour cell packs (2) – carton packs.
5 ml – neutral glass ampoules (10) – contour cell packs (5) – carton packs.
5 ml – neutral glass ampoules (10) – contour cell packs (10) – carton packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs.
Marketing Authorization Holder
Pharmaceutical Company Zdorovye, LLC (Ukraine)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml |
| Metamizole sodium | 500 mg |
1 ml – ampoules (10) – carton packs.
Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 pcs.
Marketing Authorization Holder
Pharmaceutical Company Zdorovye, LLC (Ukraine)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 1 g/2 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous and intramuscular administration | 1 ml | 1 amp. |
| Metamizole sodium | 500 mg | 1 g |
2 ml – ampoules (10) – carton packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Pharmstandard-Lexredstva OJSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – contour cell packaging.
10 pcs. – contour cell packaging (2) – cardboard packs.
10 pcs. – contour non-cell packaging.
10 pcs. – contour non-cell packaging (2) – cardboard packs.
Tablets 500 mg: 10, 20, or 5000 pcs.
Marketing Authorization Holder
Pharmstandard-Tomskkhimpharm OJSC (Russia)
Dosage Form
|
Analgin | Tablets 500 mg: 10, 20, or 5000 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – contour non-cell packaging.
10 pcs. – contour non-cell packaging (2) – cardboard packs.
10 pcs. – contour cell packaging.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
10 pcs. – contour non-cell packaging (500) – cardboard boxes.
10 pcs. – contour cell packaging (500) – cardboard boxes.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 5 or 10 pcs.
Marketing Authorization Holder
Pharmstandard-UfaVITA OJSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration as a transparent, colorless or slightly yellowish liquid.
| 1 ml | |
| Metamizole sodium | 500 mg |
Excipients: water for injections – up to 1 ml.
2 ml – glass ampoules (5) – contour cell packaging (1) – cardboard packs.
2 ml – glass ampoules (5) – contour cell packaging (2) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml 3, 5, 10, or 20 pcs.
Marketing Authorization Holder
KFK Mir, LLC (Russia)
Manufactured By
NPC Eskom, PJSC (Russia)
Dosage Form
|
Analgin | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml 3, 5, 10, or 20 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration as a transparent, colorless or yellowish liquid.
| 1 ml | |
| Metamizole sodium monohydrate | 527 mg |
| Equivalent to the content of metamizole sodium | 500 mg |
Excipients: sodium disulfite – 2 mg, disodium edetate – 0.1 mg, water for injections – up to 1 ml.
1 ml – ampoules (3) – contour cell packaging (1) – cardboard packs.
1 ml – ampoules (5) – contour cell packaging (1) – cardboard packs.
1 ml – ampoules (5) – contour cell packaging (2) – cardboard packs.
1 ml – ampoules (5) – contour cell packaging (4) – cardboard packs.
1 ml – ampoules (10) – contour cell packaging (1) – cardboard packs.
1 ml – ampoules (10) – contour cell packaging (2) – cardboard packs.
1 ml – ampoules (10) – cardboard packs with partitions.
2 ml – ampoules (3) – contour cell packaging (1) – cardboard packs.
2 ml – ampoules (5) – contour cell packaging (1) – cardboard packs.
2 ml – ampoules (5) – contour cell packaging (2) – cardboard packs.
2 ml – ampoules (5) – contour cell packaging (4) – cardboard packs.
2 ml – ampoules (10) – contour cell packaging (1) – cardboard packs.
2 ml – ampoules (10) – contour cell packaging (2) – cardboard packs.
2 ml – ampoules (10) – cardboard packs with partitions.
5 ml – ampoules (3) – contour cell packaging (1) – cardboard packs.
5 ml – ampoules (5) – contour cell packaging (1) – cardboard packs.
5 ml – ampoules (5) – contour cell packaging (2) – cardboard packs.
5 ml – ampoules (5) – contour cell packaging (4) – cardboard packs.
5 ml – ampoules (10) – contour cell packaging (1) – cardboard packs.
5 ml – ampoules (10) – contour cell packaging (2) – cardboard packs.
5 ml – ampoules (10) – cardboard packs with partitions.
Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml 5, 10, 20, or 25 pcs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml 5, 10, 20, or 25 pcs.
Marketing Authorization Holder
Ellara, LLC (Russia)
Dosage Forms
|
Analgin | Solution for intravenous and intramuscular administration 250 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml 5, 10, 20, or 25 pcs. |
| Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml 5, 10, 20, or 25 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, colorless or slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 250 mg |
Excipients: sodium disulfite – 2 mg, disodium edetate dihydrate – 0.1 mg, sodium formaldehyde sulfoxylate dihydrate – 0.5 mg, sodium hydroxide solution 1M or sulfuric acid solution 0.5M – to pH 5.0 – 7.0, water for injections – up to 1 ml.
1 ml – light-protective glass ampoules (5) – contour cell packaging (1) – cardboard packs.
1 ml – light-protective glass ampoules (5) – contour cell packaging (2) – cardboard packs.
1 ml – light-protective glass ampoules (5) – contour cell packaging (4) – cardboard packs.
1 ml – light-protective glass ampoules (5) – contour cell packaging (5) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (1) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (2) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (4) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (5) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (1) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (2) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (4) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (5) – cardboard packs.
1 ml – light-protective glass ampoules (5) – cardboard packs with an insert.
1 ml – light-protective glass ampoules (10) – cardboard packs with an insert.
2 ml – light-protective glass ampoules (5) – cardboard packs with an insert.
2 ml – light-protective glass ampoules (10) – cardboard packs with an insert.
5 ml – light-protective glass ampoules (5) – cardboard packs with an insert.
5 ml – light-protective glass ampoules (10) – cardboard packs with an insert.
Solution for intravenous and intramuscular administration transparent, colorless or slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 500 mg |
Excipients: sodium disulfite – 2 mg, disodium edetate dihydrate – 0.1 mg, sodium formaldehyde sulfoxylate dihydrate – 0.5 mg, sodium hydroxide solution 1M or sulfuric acid solution 0.5M – to pH 5.0 – 7.0, water for injections – up to 1 ml.
1 ml – light-protective glass ampoules (5) – contour cell packaging (1) – cardboard packs.
1 ml – light-protective glass ampoules (5) – contour cell packaging (2) – cardboard packs.
1 ml – light-protective glass ampoules (5) – contour cell packaging (4) – cardboard packs.
1 ml – light-protective glass ampoules (5) – contour cell packaging (5) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (1) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (2) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (4) – cardboard packs.
2 ml – light-protective glass ampoules (5) – contour cell packaging (5) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (1) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (2) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (4) – cardboard packs.
5 ml – light-protective glass ampoules (5) – contour cell packaging (5) – cardboard packs.
1 ml – light-protective glass ampoules (5) – cardboard packs with an insert.
1 ml – light-protective glass ampoules (10) – cardboard packs with an insert.
2 ml – light-protective glass ampoules (5) – cardboard packs with an insert.
2 ml – light-protective glass ampoules (10) – cardboard packs with an insert.
5 ml – light-protective glass ampoules (5) – cardboard packs with an insert.
5 ml – light-protective glass ampoules (10) – cardboard packs with an insert.
Tablets 500 mg
Marketing Authorization Holder
Rif LLC (Russia)
Manufactured By
Ozon, LLC (Russia)
Dosage Form
|
Analgin Alfactiv | Tablets 500 mg |
Dosage Form, Packaging, and Composition
Tablets
| 1 tab. | |
| Metamizole sodium | 500 mg |
10 pcs. – contour cell packaging – cardboard packs (10 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (10 pcs.) – cardboard packs (100 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (2 pcs.) – cardboard packs (20 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (20 pcs.) – cardboard packs (200 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (3 pcs.) – cardboard packs (30 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (30 pcs.) – cardboard packs (300 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (4 pcs.) – cardboard packs (40 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (5 pcs.) – cardboard packs (50 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (6 pcs.) – cardboard packs (60 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (7 pcs.) – cardboard packs (70 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (8 pcs.) – cardboard packs (80 pcs.) – Over-the-Counter
10 pcs. – contour cell packaging (9 pcs.) – cardboard packs (90 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging – cardboard packs (3 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (10 pcs.) – cardboard packs (30 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (2 pcs.) – cardboard packs (6 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (20 pcs.) – cardboard packs (60 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (3 pcs.) – cardboard packs (9 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (30 pcs.) – cardboard packs (90 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (4 pcs.) – cardboard packs (12 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (5 pcs.) – cardboard packs (15 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (6 pcs.) – cardboard packs (18 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (7 pcs.) – cardboard packs (21 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (8 pcs.) – cardboard packs (24 pcs.) – Over-the-Counter
3 pcs. – contour cell packaging (9 pcs.) – cardboard packs (27 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging – cardboard packs (4 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (10 pcs.) – cardboard packs (40 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (2 pcs.) – cardboard packs (8 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (20 pcs.) – cardboard packs (80 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (3 pcs.) – cardboard packs (12 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (30 pcs.) – cardboard packs (120 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (4 pcs.) – cardboard packs (16 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (5 pcs.) – cardboard packs (20 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (6 pcs.) – cardboard packs (24 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (7 pcs.) – cardboard packs (28 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (8 pcs.) – cardboard packs (32 pcs.) – Over-the-Counter
4 pcs. – contour cell packaging (9 pcs.) – cardboard packs (36 pcs.) – Over-the-Counter
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Avexima JSC (Russia)
Manufactured By
Avexima Siberia LLC (Russia)
Dosage Form
|
Analgin Avexima | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a slightly yellowish tint, round, flat-cylindrical in shape, with a bevel and a score.
| 1 tab. | |
| Metamizole sodium monohydrate | 500 mg |
Excipients: potato starch, talc, sucrose, calcium stearate.
10 pcs. – contour non-cell packaging.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml or 5 ml 5 or 10 pcs.
Marketing Authorization Holder
Avexima JSC (Russia)
Manufactured By
Avexima Siberia LLC (Russia)
Dosage Form
|
Analgin Avexima | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 2 ml or 5 ml 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration transparent, colorless or slightly yellowish.
| 1 ml | |
| Metamizole sodium monohydrate | 527 mg, |
| Corresponding to the content of metamizole sodium | 500 mg |
Excipients: water for injections – up to 1 ml.
2 ml – colorless glass ampoules (5) – contour cell packaging (1) – cardboard packs.
2 ml – colorless glass ampoules (5) – contour cell packaging (2) – cardboard packs.
5 ml – colorless glass ampoules (5) – contour cell packaging (1) – cardboard packs.
5 ml – colorless glass ampoules (5) – contour cell packaging (2) – cardboard packs.
Capsules 250 mg: 10 or 20 pcs.
Marketing Authorization Holder
Bryntsalov-A, JSC (Russia)
Dosage Form
|
Analgin capsule 0,25 | Capsules 250 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Capsules | 1 caps. |
| Metamizole sodium | 250 mg |
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
20 pcs. – polystyrene containers (1) – cardboard packs.
Capsules 250 mg: 10 or 20 pcs.
Marketing Authorization Holder
Sintez PJSC (Russia)
Dosage Form
|
Analgin capsule 0,25 | Capsules 250 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Capsules | 1 caps. |
| Metamizole sodium | 250 mg |
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
20 pcs. – polystyrene containers (1) – cardboard packs.
Capsules 250 mg: 10 or 20 pcs.
Marketing Authorization Holder
Pharmagen, CJSC (Russia)
Dosage Form
|
Analgin capsule 0,25 | Capsules 250 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Capsules | 1 caps. |
| Metamizole sodium | 250 mg |
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
20 pcs. – polystyrene containers (1) – cardboard packs.
Tablets 500 mg
Marketing Authorization Holder
Medisorb, JSC (Russia)
Dosage Form
|
Analgin Medisorb | Tablets 500 mg |
Dosage Form, Packaging, and Composition
Tablets
| 1 tab. | |
| Metamizole sodium | 500 mg |
10 pcs. – contour cell packs – cardboard packs (10 pcs.) – Over-the-Counter
10 pcs. – contour cell packs (2 pcs.) – cardboard packs (20 pcs.) – Over-the-Counter
10 pcs. – contour cell packs (3 pcs.) – cardboard packs (30 pcs.) – Over-the-Counter
10 pcs. – contour cell packs (4 pcs.) – cardboard packs (40 pcs.) – Over-the-Counter
10 pcs. – contour cell packs (5 pcs.) – cardboard packs (50 pcs.) – Over-the-Counter
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Obnovlenie Pfc, JSC (Russia)
Dosage Form
|
Analgin Renewal | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a yellowish tint, round, flat-cylindrical, with a bevel, with a score on one side and an engraving “R” on the other.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients: povidone K30, potato starch, talc, calcium stearate, stearic acid, colloidal silicon dioxide (aerosil).
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
Solution for intravenous and intramuscular administration 500 mg/ml
Marketing Authorization Holder
PFKO-2, LLC (Russia)
Manufactured By
Obnovlenie Pfc, JSC (Russia)
Dosage Form
|
Analgin Renewal | Solution for intravenous and intramuscular administration 500 mg/ml |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration
| 1 ml | |
| Metamizole sodium | 500 mg |
1 ml – ampoules (10 pcs.) – cardboard packs – By prescription
1 ml – ampoules (20 pcs.) – cardboard boxes – for hospitals
1 ml – ampoules (25 pcs.) – cardboard boxes – for hospitals
1 ml – ampoules (250 pcs.) – cardboard boxes – for hospitals
1 ml – ampoules (5 pcs.) – cardboard packs – By prescription
1 ml – ampoules (50 pcs.) – cardboard boxes – for hospitals
1 ml – ampoules (500 pcs.) – cardboard boxes – for hospitals
2 ml – ampoules (10 pcs.) – cardboard packs – By prescription
2 ml – ampoules (20 pcs.) – cardboard boxes – for hospitals
2 ml – ampoules (25 pcs.) – cardboard boxes – for hospitals
2 ml – ampoules (250 pcs.) – cardboard boxes – for hospitals
2 ml – ampoules (5 pcs.) – cardboard packs – By prescription
2 ml – ampoules (50 pcs.) – cardboard boxes – for hospitals
2 ml – ampoules (500 pcs.) – cardboard boxes – for hospitals
5 ml – ampoules (10 pcs.) – cardboard packs – By prescription
5 ml – ampoules (20 pcs.) – cardboard boxes – for hospitals
5 ml – ampoules (25 pcs.) – cardboard boxes – for hospitals
5 ml – ampoules (250 pcs.) – cardboard boxes – for hospitals
5 ml – ampoules (5 pcs.) – cardboard packs – By prescription
5 ml – ampoules (50 pcs.) – cardboard boxes – for hospitals
5 ml – ampoules (500 pcs.) – cardboard boxes – for hospitals
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
As-Pharm OJSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Bioreactor, LLC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Bryntsalov-A, JSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Volgograd Pharmaceutical Factory State Enterprise (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Vostok JSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Iodillia-Pharm, LLC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Lekko, CJS (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
PromExpoService, LLC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Pyatigorsk Pharmaceutical Factory LLC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
RosMedPreparaty, CJS (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Tver Pharmaceutical Factory, PJSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Trading House KhiMoptorg CJSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – contour non-cell packs (1) – cardboard packs.
10 pcs. – contour non-cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Usolye-Sibirskiy Chemical and Pharmaceutical Combine, JSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
PharmaPol, LLC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
FGP-Pharm, LLC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
FP Obolenskoe, JSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Akrikhin Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Central European Pharmaceutical Company CJS (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg: 10 or 20 pcs.
Marketing Authorization Holder
Erecton SPC, LLC (Russia)
Dosage Form
|
Analgin tablets 0,5 | Tablets 500 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – dark glass jars (1) – cardboard packs.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – polyethylene bottles (1) – cardboard packs.
Tablets 500 mg
Marketing Authorization Holder
Velpharm, LLC (Russia)
Dosage Form
|
Analgin Velpharm | Tablets 500 mg |
Dosage Form, Packaging, and Composition
Tablets
| Metamizole sodium | 500 mg |
10 pcs. – jars – cardboard packs (10 pcs.) – Over-the-Counter
10 pcs. – blister contour packs – cardboard packs (10 pcs.) – Over-the-Counter
10 pcs. – blister contour packs (2 pcs.) – cardboard packs (20 pcs.) – Over-the-Counter
10 pcs. – blister contour packs (3 pcs.) – cardboard packs (30 pcs.) – Over-the-Counter
10 pcs. – blister contour packs (4 pcs.) – cardboard packs (40 pcs.) – Over-the-Counter
10 pcs. – blister contour packs (5 pcs.) – cardboard packs (50 pcs.) – Over-the-Counter
10 pcs. – blister contour packs (6 pcs.) – cardboard packs (60 pcs.) – Over-the-Counter
20 pcs. – jars – cardboard packs (20 pcs.) – Over-the-Counter
30 pcs. – jars – cardboard packs (30 pcs.) – Over-the-Counter
40 pcs. – jars – cardboard packs (40 pcs.) – Over-the-Counter
50 pcs. – jars – cardboard packs (50 pcs.) – Over-the-Counter
60 pcs. – jars – cardboard packs (60 pcs.) – Over-the-Counter
Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml
Marketing Authorization Holder
Elzapharm, LLC (Russia)
Manufactured By
Velpharm, LLC (Russia)
Dosage Form
|
Analgin Velpharm | Solution for intravenous and intramuscular administration 500 mg/1 ml: amp. 1 ml, 2 ml, or 5 ml |
Dosage Form, Packaging, and Composition
Solution for intravenous and intramuscular administration as a transparent, colorless or slightly colored liquid.
| 1 ml | |
| Metamizole sodium monohydrate | 500 mg |
Excipients : 1M hydrochloric acid solution, water for injection.
1 ml – ampoules (10 pcs.) – cardboard packs – By prescription
1 ml – ampoules (100 pcs.) – cardboard container – for hospitals
1 ml – ampoules (240 pcs.) – cardboard container – for hospitals
1 ml – ampoules (250 pcs.) – cardboard container – for hospitals
1 ml – ampoules (480 pcs.) – cardboard container – for hospitals
1 ml – ampoules (5 pcs.) – cardboard packs – By prescription
1 ml – ampoules (500 pcs.) – cardboard container – for hospitals
2 ml – ampoules (10 pcs.) – cardboard packs – By prescription
2 ml – ampoules (100 pcs.) – cardboard container – for hospitals
2 ml – ampoules (240 pcs.) – cardboard container – for hospitals
2 ml – ampoules (250 pcs.) – cardboard container – for hospitals
2 ml – ampoules (480 pcs.) – cardboard container – for hospitals
2 ml – ampoules (5 pcs.) – cardboard packs – By prescription
2 ml – ampoules (500 pcs.) – cardboard container – for hospitals
3 ml – ampoules (10 pcs.) – cardboard packs – By prescription
3 ml – ampoules (5 pcs.) – cardboard packs – By prescription
5 ml – ampoules (100 pcs.) – cardboard container – for hospitals
5 ml – ampoules (240 pcs.) – cardboard container – for hospitals
5 ml – ampoules (250 pcs.) – cardboard container – for hospitals
5 ml – ampoules (480 pcs.) – cardboard container – for hospitals
5 ml – ampoules (500 pcs.) – cardboard container – for hospitals
Capsules 500 mg: 10, 20 or 50 pcs.
Marketing Authorization Holder
Pharmstandard-Lexredstva OJSC (Russia)
Dosage Form
|
Analgin-ExtraCap | Capsules 500 mg: 10, 20 or 50 pcs. |
Dosage Form, Packaging, and Composition
Capsules hard gelatin No. 00, white; capsule contents – white or white with a yellowish tint powder. The presence of a compacted capsule mass is allowed, which easily crumbles when pressed with a glass rod.
| 1 caps. | |
| Metamizole sodium | 500 mg |
Excipients : potato starch – 15.32 mg, calcium stearate – 4.68 mg.
Capsule shell composition (body and cap) titanium dioxide (E 171) – 2%, gelatin up to 100%
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (5) – cardboard packs.
Tablets 500 mg: 10, 20, 30, 40, 50, or 60 pcs.
Marketing Authorization Holder
Tyumen Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Analgin-LecT | Tablets 500 mg: 10, 20, 30, 40, 50, or 60 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or white with a slight yellowish tint, round, flat-cylindrical in shape, with a bevel and a score line.
| 1 tab. | |
| Metamizole sodium (calculated as monohydrate) | 500 mg |
Excipients : potato starch – 31.1 mg, talc – 10.7 mg, calcium stearate – 5.4 mg, sucrose (sugar) – 2.8 mg.
10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – non-cell contour packs (3) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (3) – cardboard packs.
10 pcs. – blister contour packs (4) – cardboard packs.
10 pcs. – blister contour packs (5) – cardboard packs.
10 pcs. – blister contour packs (6) – cardboard packs.
Tablets 500 mg: 10, 20, 30, 40, 50 and 60 pcs.
Marketing Authorization Holder
Uralbiopharm, JSC (Russia)
Dosage Form
|
Analgin-UBF | Tablets 500 mg: 10, 20, 30, 40, 50 and 60 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Metamizole sodium | 500 mg |
10 pcs. – non-cell contour packs.
10 pcs. – blister contour packs.
20 pcs. – polymer jars.
30 pcs. – polymer jars.
40 pcs. – polymer jars.
50 pcs. – polymer jars.
60 pcs. – polymer jars.
Film-coated tablets, 500 mg: from 5 to 420 pcs.
Marketing Authorization Holder
Aliym, JSC (Russia)
Dosage Form
|
Analgin-Ultra | Film-coated tablets, 500 mg: from 5 to 420 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets pink, biconvex, oblong in shape with rounded ends, with a score line; on the cross-section the core is white or almost white.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients : potato starch, microcrystalline cellulose, colloidal silicon dioxide (aerosil), hypromellose (hydroxypropyl methylcellulose), crospovidone, magnesium stearate, talc.
Shell composition Opadry II 85F34555 pink [polyvinyl alcohol, titanium dioxide, macrogol, talc, aluminum lake based on brilliant red dye, aluminum lake based on sunset yellow dye, aluminum lake based on azorubine dye].
From 5 to 30 pcs. – blister contour packs (from 1 to 14 pcs.) – cardboard packs.
Film-coated tablets, 500 mg: 5, 10 or 20 pcs.
Marketing Authorization Holder
FP Obolenskoe, JSC (Russia)
Manufactured By
Kirov Pharmaceutical Company, LLC (Russia)
Or
PharmVILAR NPO, LLC (Russia)
Dosage Form
|
Analgin-Ultra | Film-coated tablets, 500 mg: 5, 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets pink, biconvex, oblong in shape with rounded ends, with a score line; on the cross-section the core is white or almost white.
| 1 tab. | |
| Metamizole sodium | 500 mg |
Excipients : potato starch, microcrystalline cellulose, colloidal silicon dioxide (aerosil), hypromellose (hydroxypropyl methylcellulose), crospovidone, magnesium stearate, talc.
Shell composition opadry II 85F34555 pink [polyvinyl alcohol, titanium dioxide, macrogol, talc, aluminum lake based on brilliant red dye, aluminum lake based on sunset yellow dye, aluminum lake based on azorubine dye].
5 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
20 pcs. – blister contour packs (1) – cardboard packs.
![Analgin [Tablets, Capsules, Solution] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Analgin [Tablets, Capsules, Solution] 2")